<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Revisiting Central Metabolism Bloodstream <br /> Forms Trypanosoma brucei: Production Acetate in <br /> the Mitochondrion Is Essential Parasite Viability <br /> Muriel Mazet1, Pauline Morand1, Marc Biran1, Guillaume Bouyssou2, Pierrette Courtois3, <br /> Sylvie Dauloue`de3, Yoann Millerioux1, Jean-Michel Franconi1, Philippe Vincendeau3, Patrick Moreau2, <br /> Fre&#194;&#180;de&#194;&#180;ric Bringaud1* <br /> 1 Centre Re&#194;&#180;sonance Magne&#194;&#180;tique des Syste`mes Biologiques (RMSB), UMR5536, Universite&#194;&#180; Bordeaux Segalen, CNRS, Bordeaux, France, 2 Laboratoire Biogene`se <br /> Membranaire, UMR5200 Universite&#194;&#180; Bordeaux Segalen, CNRS, Ba&#203;&#8224;timent A3, INRA Bordeaux Aquitaine, Villenave d&#226;&#8364;&#8482;Ornon, France, 3 Laboratoire Parasitologie, UMR177 <br /> IRD CIRAD, Universite&#194;&#180; Bordeaux Segalen, BP 43, Bordeaux, France <br />  <br />  <br />  <br />      <span id='am-1' about='protege:abstract' typeof='owl:Thing'>Abstract</span> <br />      Background: The bloodstream forms Trypanosoma brucei, causative agent sleeping sickness, rely solely on <br />      glycolysis ATP production. It generally accepted pyruvate major end-product excreted glucose <br />      metabolism proliferative long-slender bloodstream forms parasite, virtually production succinate <br />      acetate, main end-products excreted glycolysis trypanosomatid adaptative forms, including <br />      procyclic insect form T. brucei. <br />  <br />      Methodology/Principal Findings: A comparative NMR analysis showed bloodstream long-slender procyclic <br />      trypanosomes excreted equivalent amounts acetate succinate glucose metabolism. Key enzymes acetate <br />      production glucose-derived pyruvate threonine expressed mitochondrion long-slender forms, <br />      produces 1.4-times acetate glucose threonine presence equal both <br />      carbon sources. By using combination reverse genetics NMR analyses, showed mitochondrial production of <br />      acetate essential long-slender forms, blocking acetate biosynthesis carbon sources induces cell <br />      death. This confirmed absence threonine lethal <span id='am-88' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-89' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-90' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-91' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-92' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-93' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-94' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-96' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-98' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-100' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-103' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-104' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-105' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-106' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-107' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-108' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-109' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-110' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-111' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-114' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-115' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-116' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-117' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-118' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-119' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-120' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-126' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-127' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-128' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-130' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-131' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-133' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-134' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-135' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-136' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-137' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-139' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-140' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-142' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-143' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-144' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-145' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-146' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-147' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-148' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-150' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-151' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-152' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-153' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-154' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-155' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-157' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-158' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-159' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-160' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-161' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-162' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-163' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-164' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-165' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span>phenotype</span> RNAi-mediated depletion pyruvate <br />      dehydrogenase, involved glucose-derived acetate production. In addition, showed novo fatty acid <br />      biosynthesis acetate essential parasite, demonstrated <span id='am-166' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-167' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-168' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-169' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-170' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-171' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-172' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-173' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-174' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-175' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-176' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-177' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-178' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-179' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-180' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-181' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-182' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-183' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-184' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-185' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-186' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-187' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-188' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-189' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-190' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-191' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-192' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-193' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-194' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-195' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-196' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-197' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-198' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-199' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-200' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-201' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-202' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-203' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-204' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-205' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-206' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-207' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-208' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-209' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-210' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-211' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-212' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-213' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-214' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-215' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-216' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-217' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-218' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-219' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-220' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-221' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-222' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-223' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-225' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-226' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-228' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-229' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-231' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-232' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-233' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-234' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-235' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-236' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-237' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-238' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-239' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-240' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-241' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-242' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-243' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span>lethal phenotype</span> metabolic analyses of <br />      RNAi-mediated depletion acetyl-CoA synthetase, catalyzing cytosolic step pathway. <br />  <br />      Conclusions/Significance: Acetate produced mitochondrion glucose threonine synthetically essential for <br />      long-slender mammalian forms T. brucei feed <span id='am-3' about='Thesaurus:Essential_Fatty_Acid' typeof='owl:Thing'>essential fatty acid</span> biosynthesis &#226;&#8364;&#732;&#226;&#8364;&#732;acetate shuttle&#226;&#8364;&#8482;&#226;&#8364;&#8482; <br />      recently described procyclic insect form parasite. Consequently, key enzymatic steps pathway, <br />      particularly acetyl-CoA synthetase, constitute new attractive drug targets trypanosomiasis. <br />  <br />   Citation: Mazet M, Morand P, Biran M, Bouyssou G, Courtois P, et al. (2013) Revisiting Central Metabolism Bloodstream Forms Trypanosoma brucei: <br />   Production Acetate Mitochondrion Is Essential Parasite Viability. PLoS Negl Trop Dis 7(12): e2587. doi:10.1371/journal.pntd.0002587 <br />   Editor: Reza Salavati, McGill University, Canada <br />   Received July 31, 2013; Accepted October 30, 2013; Published December 19, 2013 <br />   Copyright: &#195;&#376; 2013 Mazet et al. This open-access article distributed terms Creative Commons Attribution License, permits <br />   unrestricted use, distribution, reproduction medium, provided original author source credited. <br />   Funding: This work supported Agence Nationale la Recherche (ANR) grant ACETOTRYP ANR-BLANC-2010 FB PMoreau <br />   (http://www.agence-nationale-recherche.fr/). FB supported Centre National la Recherche Scientifique (CNRS, http://www.cnrs.fr/), Universite&#194;&#180; <br />   Bordeaux Segalen (http://www.univ-bordeauxsegalen.fr/fr/index.html), ParaMet PhD programme Marie Curie Initial Training Network (FP7) (http://www. <br />   paramet.eu/), Conseil Re&#194;&#180;gional d&#226;&#8364;&#8482;Aquitaine (http://aquitaine.fr/). FB PV supported Laboratoire d&#226;&#8364;&#8482;Excellence (LabEx) ParaFrap ANR-11-LABX- <br />   0024 (http://www.agence-nationale-recherche.fr/investissementsdavenir/AAP-LABEX-2011.html). The funders role study design, data collection and <br />   analysis, decision publish, preparation manuscript. <br />   Competing Interests: The authors declared competing interests exist. <br />   * E-mail: bringaud@rmsb.u-bordeaux2.fr. <br />  <br />  <br />  <br /> Introduction                                                                           mammalian host, pleomorphic BSF strains proliferate as <br />                                                                                        &#226;&#8364;&#732;&#226;&#8364;&#732;long-slender&#226;&#8364;&#8482;&#226;&#8364;&#8482; BSF (LS-BSF) differentiate non- <br />    Trypanosoma brucei unicellular eukaryote, belonging                     proliferative &#226;&#8364;&#732;&#226;&#8364;&#732;short-stumpy&#226;&#8364;&#8482;&#226;&#8364;&#8482; trypanosomes (SS-BSF), are <br /> protozoan order Kinetoplastida causes sleeping sickness                        preadapted differentiation PF insect midgut [2]. The <br /> humans economically important livestock diseases [1]. This                         environmental changes encountered parasite require <br /> parasite undergoes complex life cycle transmission                       significant morphological metabolic adaptations, exempli- <br /> the bloodstream mammalian host (bloodstream forms                          fied important qualitative quantitative differences in <br /> parasite - BSF) alimentary tract (procyclic form - PF)                      glucose metabolism BSF PF [3,4]. <br /> salivary glands (epimastigote metacyclic forms) blood                             PF living tsetse fly midgut &#226;&#8364;&#8220; glucose scarce or <br /> feeding insect vector, tsetse fly. In bloodstream                       absent &#226;&#8364;&#8220; developed elaborate energy metabolism based on <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                                1                            December 2013 | Volume 7 | Issue 12 | e2587 <br />                                                                                                    Acetate Shuttle Is Essential BSF Trypanosomes <br />  <br />  <br />  <br />   Author Summary                                                              alanine reported [14,17]. These minor glycolytic end- <br />                                                                               products thought produced &#226;&#8364;&#732;&#226;&#8364;&#732;contaminating&#226;&#8364;&#8482;&#226;&#8364;&#8482; non- <br />   Many protists, including parasitic helminthes, trichomo-                    proliferative SS-BSF trypanosomes developed more <br />   nads trypanosomatids, produce acetate                          elaborated central metabolism number PF traits, <br />   mitochondrion mitochondrion-like organelle,                     including production acetate succinate glycolysis <br />   excreted main metabolic end-product energy                    [18,19]. Consequently, recent reports consider LS-BSF <br />   metabolism. We recently demonstrated mito-                        trypanosomes produce acetate glucose. In the <br />   chondrial production acetate <span id='am-4' about='Thesaurus:Essential_Fatty_Acid' typeof='owl:Thing'>essential fatty acid</span>                 seventies, acetate production reported threonine <br />   biosynthesis ATP production procyclic insect                     degradation PF BSF trypanosomes [12], however, this <br />   form T. brucei. However, acetate metabolism                      metabolic pathway investigated. <br />   investigated long-slender bloodstream forms                        Here investigated role glucose threonine <br />   parasite, proliferative forms responsible the <br />                                                                               degradation acetate production monomorphic 427 BSF <br />   sleeping sickness. In contrast current view, we <br />                                                                               strain, proliferates LS-BSF trypanosomes lost the <br />   showed bloodstream forms produce as <br />   acetate glucose procyclic parasites.                     ability differentiate non-proliferative SS-BSF [20,21]. This <br />   Acetate production glucose threonine                            BSF cell line produces excretes acetate, minor end- <br />   synthetically essential growth novo synthesis                    product glucose metabolism, metabolic flux same <br />   fatty acids bloodstream trypanosomes. These                       range observed PF. Glucose threonine contribute almost <br />   data highlight central metabolism                           equally acetate production, essential viability of <br />   bloodstream forms contains unexpected essential path-                       proliferative BSF trypanosomes, demonstrated reverse <br />   ways, minor terms metabolic flux,                      genetics approaches. Our data reveal unexpected metabolic <br />   targeted development trypanocidal                       similarities PF LS-BSF trypanosomes. <br />   drugs. <br />                                                                               Materials Methods <br />  <br /> amino acids, proline. However, grown standard                 Growth maintenance trypanosomes <br /> glucose-rich conditions, prefer glucose proline carbon              The bloodstream form T. brucei 427 90-13 (TetR-HYG <br /> source [5,6]. PF converts glucose partially oxidized             T7RNAPOL-NEO), 427 221a line (MiTat 1.2) designed the <br /> excreted end-products, acetate succinate,                conditional expression genes, cultured 37uC IMDM <br /> glycolysis taking place specialized peroxisomes called glycosomes          (Iscove&#226;&#8364;&#8482;s Modified Dulbecco&#226;&#8364;&#8482;s Medium, Life Technologies) supplemented <br /> [7]. In course glycolysis, phosphoenolpyruvate (PEP)                10% (v/v) heat-inactivated fetal calf serum (FCS), 0.25 mM <br /> produced cytosol, located branching point          &#195;&#376;-mercaptoethanol, 36 mM NaHCO3, 1 mM hypoxanthine, <br /> feed glycosomal &#226;&#8364;&#732;succinate branch&#226;&#8364;&#8482; mitochondrial                  0.16 mM thymidine, 1 mM sodium pyruvate, 0.05 mM bath- <br /> &#226;&#8364;&#732;acetate succinate branches&#226;&#8364;&#8482; (see Fig. 1). For &#226;&#8364;&#732;&#226;&#8364;&#732;succinate            ocuprone 2 mM L-cysteine [22]. <span id='am-9' about='protege:TO' typeof='owl:Thing'>To</span> prepare threonine- <br /> branches&#226;&#8364;&#8482;&#226;&#8364;&#8482;, PEP re-enter glycosomes converted            depleted IMDM medium compounds constituting the <br /> into malate succinate compartment. Malate,              medium, threonine, purchased Sigma-Aldrich. <br /> moves glycosomes mitochondrion,                 The procyclic form T. brucei EATRO1125 cultured at <br /> converted succinate therein. Additionally, PEP                    27uC SDM79 medium containing 10% (v/v) heat-inactivated <br /> converted cytosol pyruvate feed &#226;&#8364;&#732;acetate branch&#226;&#8364;&#8482;           fetal calf serum 35 mg/mL hemin [23]. <br /> (steps 1&#226;&#8364;&#8220;4 Fig. 1). In mitochondrion, pyruvate converted by <br /> the pyruvate dehydrogenase complex (PDH, EC 1.2.4.1, step 1)             Gene knock TDH <br /> acetyl-CoA acetate different enzymes, i.e.                  Replacement threonine-3-dehydrogenase (TDH: <br /> acetate:succinate CoA transferase (ASCT, EC 2.8.3.8, step 2)              Tb927.6.2790) puromycin (PAC) blasticidin (BSD) <br /> acetyl-CoA thioesterase (ACH, EC 3.1.2.1, step 3) [8&#226;&#8364;&#8220;10]. In PF,              resistance markers homologous recombination performed <br /> acetate production plays important role mitochondrial ATP              DNA fragments containing resistance marker gene flanked <br /> production ASCT/SCoAS cycle (steps 2 4), ACH                 TDH UTR sequences. The TDH knock generated <br /> is involved ATP production [10]. Acetate                   427 90-13 BSF parental cell line, constitutively <br /> produced threonine, major carbon source PF present               expresses T7 RNA polymerase gene tetracycline <br /> the vitro medium [6,11,12]. This amino acid converted              repressor control T7 RNA polymerase promoter for <br /> acetate threonine-3-dehydrogenase (TDH, EC 1.1.1.103, step 5),             tetracycline inducible expression (TetR-HYG T7RNAPOL-NEO) <br /> acetyl-CoA:glycine C acetyltransferase (EC 2.3.1.29, step 6)              [24]. Transfection selection drug-resistant clones were <br /> probably ASCT and/or ACH. We recently showed PF uses                   performed previously reported using Nucleofactor system <br /> new metabolic pathway observed PF trypanosomes far,                [25]. The second TDH alleles replaced by <br /> named &#226;&#8364;&#732;&#226;&#8364;&#732;acetate shuttle&#226;&#8364;&#8482;&#226;&#8364;&#8482;, transfers acetyl-CoA            puromycin- blasticidin-resistant genes, respectively. Trans- <br /> mitochondrion cytosol feed essential cytosolic fatty acid       fected cells selected IMDM medium containing hygro- <br /> biosynthesis [13]. In shuttle, acetate produced                   mycin B (5 mg/mL), neomycin (2.5 mg/mL), puromycin (0.1 mg/ <br /> mitochondrion acetyl-CoA exported cytosol                  mL) blasticidin (10 mg/mL). The selected cell line (TetR-HYG <br /> converted acetyl-CoA cytosolic acetyl-CoA                    T7RNAPOL-NEO Dtdh::PAC/Dtdh::BSD) called Dtdh. <br /> synthetase (AMP-dependent enzyme, AceCS, EC 6.2.1.1, step 7). <br />    In contrast PF, BSF trypanosomes rely glucose               Inhibition gene expression RNAi <br /> their energy production, 5- 10-fold higher rate glucose             Accession numbers (http://www.genedb.org/genedb/tryp/) of <br /> consumption [14]. It generally accepted proliferative             genes targeted RNAi, acetyl-CoA synthetase (AMP-dependent <br /> LS-BSF grown aerobiosis convert glucose exclusively                enzyme, AceCS) E2 subunit pyruvate dehydrogenase <br /> pyruvate [15,16], excretion trace amounts                complex (PDH-E2), Tb927.8.2520 Tb927.10.7570, <br /> incompletely oxidized end-products glycerol, succinate            respectively. RNAi-mediated inhibition gene expression the <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                       2                        December 2013 | Volume 7 | Issue 12 | e2587 <br />                                                                                                       Acetate Shuttle Is Essential BSF Trypanosomes <br />  <br />  <br />  <br />  <br /> Figure 1. Schematic representation acetate production glucose threonine BSF. Black arrows indicate enzymatic steps of <br /> glucose threonine metabolism double line arrow represents novo biosynthesis fatty acids. Excreted end-products metabolism of <br /> glucose threonine boxed. The arrows illustrate high glycolytic flux leading production pyruvate, accounts 85.1% of <br /> the excreted end-products glucose metabolism. Abbreviations: AcCoA, acetyl-CoA; AOB, amino oxobutyrate; DHAP, dihydroxyacetone <br /> phosphate; G3P, glyceraldehyde 3-phosphate; MAL, malate; PEP, phosphoenolpyruvate; PYR, pyruvate; SCoA, succinyl-CoA. Indicated enzymes are: 1, <br /> pyruvate dehydrogenase complex (PDH); 2, acetate:succinate CoA-transferase (ASCT); 3, acetyl-CoA thioesterase (ACH); 4, succinyl-CoA synthetase <br /> (SCoAS); 5, threonine 3-dehydrogenase (TDH); 6, 2-amino-3-ketobutyrate coenzyme A ligase (AKCT); 7, acetyl-CoA synthetase (AMP-dependent <br /> enzyme, AceCS). <br /> doi:10.1371/journal.pntd.0002587.g001 <br />  <br />  <br /> 427 90-13 BSF parental cell line performed expression                 pET28a expression vectors (Novagen) express BL21 <br /> stem-loop &#226;&#8364;&#732;&#226;&#8364;&#732;sense/anti-sense&#226;&#8364;&#8482;&#226;&#8364;&#8482; RNA molecules targeted                    Escherichia coli TDH protein preceded N-terminal histidine <br /> sequences introduced pHD1336 (kindly provided C.                    tag (6 histidine codons). Cells harvested centrifugation, <br /> Clayton, ZMBH, Heidelberg, Germany, cclayton@zmbh.uni-                          recombinant proteins purified nickel chelation chroma- <br /> heidelberg.de). The AceCS-SAS PDH-E2-SAS &#226;&#8364;&#732;&#226;&#8364;&#732;sense/anti-                      tography (Novagen) insoluble fraction according the <br /> sense&#226;&#8364;&#8482;&#226;&#8364;&#8482; constructs generated pLew100 vector                   manufacturer&#226;&#8364;&#8482;s instructions. The anti-TDH immune serum was <br /> (kindly provided E. Wirtz G. Cross) [24] described                    raised rabbits injections 15-day intervals 100 mg of <br /> before [5,13]. Then AceCS-SAS PDH-E2-SAS HindIII-                       TDH-His recombinant nickel-purified proteins, emulsified with <br /> BamHI cassettes extracted pLew100 plasmids                        complete (first injection) incomplete Freund&#226;&#8364;&#8482;s adjuvant <br /> inserted HindIII-BamHI digested pHD1336 vector,                        (Proteogenix S.A.). Antibodies raised T. brucei TDH <br /> contains blasticidin resistance gene. The RNAi-harboring                    protein expressed E. coli recognize single 36.5 kDa protein in <br /> RNAi <br />      AceCS RNAiPDH single mutant cell lines produced                   western blots, corresponding calculated TDH molecular <br /> by transfection 427 90-13 cell line NotI-linearized             weight (36.96 kDa). <br /> pHD-AceCS-SAS pHD-PDH-E2-SAS plasmids, respectively, <br /> and selected IMDM medium containing hygromycin B (5 mg/                      Western blot analyses <br /> mL), neomycin (2.5 mg/mL) blasticidin (10 mg/mL). For                          Total protein extracts bloodstream procyclic forms T. brucei <br /> transfection Dtdh cell line pLew-PDH-E2-SAS                     (56106 cells) separated SDS PAGE (10%) immuno- <br /> construct, antibiotics used select Dtdh cell line,       blotted Immobilon-P filters (Millipore) [26]. Immunodetection <br /> in addition phleomycin (2.5 mg/mL), included                     performed described [26,27] using primary antibodies, the <br /> medium select double mutant cell lines.                                      mouse anti-sera AceCS diluted 1:100 [13], PDH-E2 diluted <br />                                                                                 1:500 [28] heat shock protein 60 (hsp60) diluted 1:10,000 [29], <br /> Production TDH antibodies                                                    rabbit anti-sera TDH diluted 1:500, acetate:succinate <br />   A recombinant fragment containing full-<span id='am-6' about='xsp:length' typeof='owl:Thing'>length</span> TDH gene                    CoA-transferase (ASCT) diluted 1:100 [9], acetyl-CoA thioesterase <br /> was inserted NdeI BamHI restriction sites                   (ACH) diluted 1:500 [10] glycerol-3-phosphate dehydrogenase <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                         3                         December 2013 | Volume 7 | Issue 12 | e2587 <br />                                                                                                   Acetate Shuttle Is Essential BSF Trypanosomes <br />  <br />  <br /> (GPDH, EC 1.1.1.8) diluted 1:100 [30]. Goat anti-rabbit Ig/                  pyruvate, leucine, isoleucine, valine, containing 25 mM glucose, <br /> peroxidase (1:10,000 dilution) goat anti-mouse Ig/peroxidase              100 mM acetate 40 mCi [1-14C]-acetate (55.3 mCi/mmol). <br /> were used secondary antibody revelation performed                 Cells checked microscopically viability times <br /> using SuperSignal West Pico Chemiluminescent Substrate                incubation. Subsequently, lipids extracted chlor- <br /> described manufacturer (Thermo Scientific). Images               oform:methanol (2:1, v/v) 30 min room temperature, and <br /> acquired analyzed KODAK Image Station 4,000 MM                    washed times 0.9% NaCl. The washed lipid <br /> and quantitative analyses performed KODAK MI                   extracts evaporated lipids dissolved 1 mL of <br /> application.                                                                 methanol:H2SO4 (40:1, v/v). Trans-esterification fatty acids <br />                                                                              lipids performed 80uC 60 min. After cooling the <br /> Enzyme assays                                                                samples, 400 mL hexane (99% pure) 1.5 mL H2O were <br />    Cells washed PBS lysed sonication (5 sec 4uC)        added, mixture homogenized vigorously 20 sec. <br /> hypotonic lysis buffer (5 mM Na2HPO4, 0.3 mM KH2PO4). Deter-                 The samples centrifuged 5 min 1,000 g to <br /> mination TDH PDH enzymatic activities performed using             separate phases, hexane upper phases containing fatty <br /> a spectrophotometric assay described [12,31,32].                   acid methyl ester (FAMEs) recovered contact with <br />                                                                              lower phases. FAMEs loaded HPTLC plates <br />                                                                              developed hexane/ethylether/acetic acid (90:15:2, v/v) and <br /> Immunofluorescence analysis <br />                                                                              separated (RF 0.90). They identified co-migration <br />    To stain mitochondria wild-type cell lines, 200 nM <br />                                                                              known standards. Their radio-labeling determined <br /> MitoTracker Red CMXRos (Invitrogen) added culture, <br />                                                                              STORM 860 (GE Healthcare). The values were <br /> followed 20 min incubation washes PBS. Then wild-type <br />                                                                              normalized amounts total esters sample and <br /> cells fixed 4% formaldehyde PBS, permeabilized 1%          detected densitometry analysis using TLC scanner 3 <br /> Triton X-100, spread poly-L-lysine-coated slides. The slides          (CAMAG, Muttenz, Switzerland) described [13]. <br /> were incubated 45 min PBS containing 5% BSA, followed <br /> by incubation PBS 2% BSA primary antiserum, 1:50 <br /> diluted rabbit anti-TDH, mouse anti-AceCS mouse anti-PDH-E1a. <br />                                                                              In vivo experiments <br /> After washing PBS, slides incubated 2 mg/mL                  Eight- ten-week-old female BALB/c mice bred SAS <br /> Alexa 594 anti-rabbit IgG conjugate Alexa Fluor 594 anti-mouse            Centre d&#226;&#8364;&#8482;Elevage Depre&#194;&#180; (Saint Doulchard, France) housed <br />                                                                              conventional conditions, food water administered <br /> IgG conjugate (Molecular Probes). Slides washed and <br />                                                                              ad libitum, according institutional guidelines. Twelve mice per <br /> mounted SlowFade antifade reagent (Invitrogen). Cells were <br />                                                                              group immunocompromised intraperitoneal injection of <br /> visualized Leica DM5500B microscope, images were <br />                                                                              300 mg/kg Endoxan 48 h prior infection infected <br /> captured ORCA-R2 camera (Hamamatsu) Leica MM AF <br />                                                                              single intraperitoneal injection 104 parasites suspended in <br /> Imaging System software (MetaMorph). <br />                                                                              0.3 mL fresh IMDM medium. Where appropriate, 1 mg/mL <br />                                                                              doxycycline 50 g/L saccharose added 48 h the <br /> NMR experiments                                                              drinking water starting days prior infection. Four <br />    The bloodstream forms (2.56107 cells, ,0.25 mg proteins)            experimental groups studied: animals infected wild- <br /> procyclic form (56107 cells, ,0.25 mg proteins) T. brucei         type parasites (group 1) doxycycline (group 2) in <br /> collected centrifugation 1,400 g 10 min, washed once/              drinking water, animals infected c RNAiPDH.ni cell <br /> twice phosphate-buffered saline (PBS) incubated 5 h          line (group 3) animals infected RNAiPDH.i cell line <br /> 37uC 2.5 mL incubation buffer (PBS supplemented 5 g/L             cultured 48 h presence doxycycline pre-induce <br /> NaHCO3, pH 7.4), [U-13C]-glucose (4 mM) presence              down-regulation PDH-E2 expression kept with <br /> the absence threonine (4 mM). The experiments                   doxycycline drinking water (group 4). To prevent the <br /> performed regular 12C glucose carbon source. The            phenotypic reversion commonly observed BSF mutants, the <br /> integrity cells incubation checked                  injected RNAiPDH.i cell line selected fresh transfection <br /> microscopic observation. 50 mL maleate (20 mM) added                 maintained vitro 4 weeks post-transfection before <br /> as internal reference 500 mL aliquot collected supernatant       injecting animals. Efficient down-regulation PDH-E2 <br /> and proton NMR (1H-NMR) spectra performed                            expression confirmed western blot threonine- <br /> 125.77 MHz Bruker DPX500 spectrometer equipped                   dependency selected cell line confirmed vitro. The <br /> 5 mm broadband probe head. Measurements recorded                     health status animals monitored daily basis and <br /> 25uC ERETIC method. This method provides                          parasitaemias counted daily. <br /> electronically synthesized reference signal [33]. Acquisition condi- <br /> tions follows: 90u flip angle, 5,000 Hz spectral width, 32 K         Ethics statement <br /> memory size, 9.3 sec total recycle time. Measurements                  Experiments, maintenance care mice complied with <br /> performed 256 scans total time close 40 min. Before            guidelines European Convention Protection of <br /> each experiment, phase ERETIC peak precisely                  Vertebrate Animals used Experimental Scientific <br /> adjusted. Resonances obtained spectra integrated             Purposes (CETS nu123). Experiments approved the <br /> results expressed relative ERETIC peak integration. The              Department protection animals plants the <br /> linear production pyruvate acetate experi-             Pre&#194;&#180;fecture la Gironde (Identification number A33-063-324). <br /> ment confirmed 1H-NMR quantification end- <br /> products excreted wild type trypanosomes incubated 6 h <br />                                                                              Results <br /> in PBS containing 4 mM [U-13C]-glucose (data shown). <br />                                                                              Acetate essential lipid biosynthesis BSF <br /> Fatty acid labeling [U-14C]-acetate                                        PF depend acetate produced mitochondrion feed <br />    Cells late exponential phase (56107 cells) incubated          fatty acid biosynthesis essential enzyme AceCS [13]. A <br /> for 16 h 10 mL modified IMDM medium threonine,                 western blot analysis showed AceCS (74 kDa) expressed <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                      4                        December 2013 | Volume 7 | Issue 12 | e2587 <br />                                                                                               Acetate Shuttle Is Essential BSF Trypanosomes <br />  <br />  <br />  <br />  <br /> Figure 2. Expression immunolocalization enzymes involved acetate metabolism. In Panel A, expression AceCS, ASCT, ACH, <br /> PDH-E2 TDH analyzed western blotting specific immune sera total protein lysates (56106 cells lane) wild-type 427 <br /> monomorphic bloodstream forms (LS-BSF) procyclic cells (PF). The anti-hps60 antibodies used loading controls. The positions the <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                   5                       December 2013 | Volume 7 | Issue 12 | e2587 <br />                                                                                                     Acetate Shuttle Is Essential BSF Trypanosomes <br />  <br />  <br />  <br /> molecular weight markers indicated kDa right margin panel. The PDH TDH activities (milliunits/mg protein) were <br /> determined forms parasite. The &#226;&#8364;&#732;&#226;&#8364;&#732;6&#226;&#8364;&#8482;&#226;&#8364;&#8482; signs indicate SD 3 independent experiments. In panel B, bloodstream cells stained <br /> with mouse anti-AceCS (Alexa 488 channel), mouse anti-PDH-E1a (Alexa 488 channel) rabbit anti-TDH (Alexa 488 channel) MitoTracker as <br /> mitochondrial control. Differential interference contrast (DIC) cells shown left panel. Scale bar, 1 mm. <br /> doi:10.1371/journal.pntd.0002587.g002 <br />  <br />  <br /> at level BSF PF, immunofluorescence                As expected, BSF mainly converted glucose pyruvate <br /> analysis using anti-AceCS immune serum showed homoge-                   (7761 nmol/h/108 cells), accounts 85.1% the <br /> neous diffuse <span id='am-244' about='xsp:pattern' typeof='owl:Thing'>pattern</span> characteristic cytoplasmic localization            excreted end-products. In addition, BSF excreted significant <br /> (Fig. 2), suggesting pathway exist BSF. AceCS           amounts alanine, acetate succinate, represent <br /> is essential BSF viability, demonstrated death           9.2%, 4.9% 0.8% excreted end-products glucose <br /> RNAi <br />      AceCS.i cell line days post-induction down-regulation           metabolism, respectively (Table 1). Surprisingly, rate of <br /> of AceCS gene expression (.ni .i stands uninduced             excretion 13C-enriched acetate succinate [U-13C]- <br /> tetracycline-induced, respectively) (Fig. 3A). To investigate role        glucose 2-fold lower BSF PF (446 versus <br /> of AceCS, radiolabel incorporation fatty acids [1-14C]-             789 nmol acetate/h/108 cells 71 versus 156 nmol of <br /> acetate measured parental RNAiAceCS cell lines                succinate/h/108 cells, respectively) (Table 1, Fig. 4). The <br /> incubated IMDM medium. <span id='am-5' about='rdfs:label' typeof='owl:Thing'>Label</span> incorporation fatty                  unexpected similar rate acetate succinate excretion both <br /> acids reduced 2.1- 8.1-fold days                    trypanosome forms probably ,10-fold higher <br /> tetracycline addition, respectively, correlates                glycolytic rate BSF (the rate glycolytic end-product excretion <br /> reduction AceCS expression (Fig. 3B). Altogether data                9.4-fold higher BSF compared PF - Table 1). <br /> demonstrate proliferative BSF require acetate feed                Consequently, high glycolytic rate BSF combined the <br /> <span id='am-7' about='Thesaurus:Essential_Fatty_Acid' typeof='owl:Thing'>essential fatty acid</span> biosynthetic pathway, previously observed          dominant conversion glucose pyruvate (85.1% the <br /> PF [13].                                                                      excreted end-products) led underestimation the <br />                                                                               role acetate succinate production LS-BSF, their <br /> BSF express enzymes involved acetate production                            rate production range PF. <br /> <span id='am-2' about='protege:FROM' typeof='owl:Thing'>from</span> glucose threonine                                                       To confirm acetate production glucose metabolism LS- <br />    The IMDM medium does contain acetate, minor                 BSF, conducted RNAi-mediated down-regulation expression <br /> contribution 10% FCS supplement (,5 mM) [34].                          PDH-E2 gene. The RNAiPDH.i cell line showed growth <br /> Consequently, LS-BSF produce acetate catabolic                   phenotype tetracycline induction (Fig. 6A), the <br /> pathways previously identified PF, i.e. mitochondrial production           PDH-E2 protein longer detectable western blot two <br /> of acetyl-CoA glucose threonine degradation                  days post-induction (Fig. 6A, inset). Metabolite profiling the <br />                                                                               RNAi <br /> PDH TDH, respectively [3], followed conversion acetyl-                   PDH.i cell line incubated presence 4 mM [U-13C]- <br /> CoA acetate mitochondrial enzymes, ASCT [9]                   glucose showed 13.7-fold reduction acetate production from <br /> ACH [10]. A western blot analysis showed ASCT (54 kDa),                  glucose compared RNAiPDH.ni cells (55 versus 755 nmol/h/ <br /> ACH (40.5 kDa), PDH-E2 (E2 subunit PDH, 49.6 kDa)                      108 cells) (Table 1). It note that, unknown reasons, the <br /> TDH (39.5 kDa) expressed 427 BSF strain,                 uninduced RNAiPDH.ni cell line produces ,1.7-times acetate <br /> lost ability differentiate SS-BSF (Fig. 2A). This             glucose parental cells. <br /> confirmed determination PDH TDH activities in <br /> LS-BSF, 4-fold 6.7-fold lower PF,                         Mitochondrial production acetate essential BSF <br /> respectively (Fig. 2A). Immunofluorescence analyses revealed                     Since BSF PF reported produce acetate <br /> colocalization PDH-E1a (E1a subunit PDH) TDH                   threonine [12], present IMDM medium <br /> the mitochondrion-specific dye MitoTracker Red CMXRos                         (0.9 mM), investigated threonine degradation pathway in <br /> (Invitrogen) (Fig. 2B). The mitochondrial localization TDH              BSF. Incubation parasites threonine-depleted medium, <br /> consistent 24-amino-acid N-terminal mitochondrial target-              contains ,15 mM amino acid coming FCS <br /> ing signal predicted MitoProt (http://ihg.gsf.de/ihg/mitoprot.             [35], did affect growth wild-type RNAiPDH.ni cells, <br /> html) high probability (0.82). Since BSF express             growth RNAiPDH.i mutant abolished (Fig. 6D). To <br /> set enzymes required acetate production, used                confirm glucose threonine degradations contribute to <br /> combination reverse genetics PDH-E2 TDH                         acetate production, pathways interrupted down- <br /> metabolic profiling NMR investigate mitochondrial acetate               regulating PDH-E2 expression TDH null background <br /> production BSF.                                                            (Dtdh/RNAiPDH cell line). First, TDH alleles replaced by <br />                                                                               puromycin (PAC) blasticidin (BSD) markers Dtdh cell <br /> BSF PF produce equivalent amounts acetate                         line, effect growth rate (Fig. 6C). Deletion TDH <br /> glucose                                                                       alleles confirmed PCR analyses (Fig. 6B), western blot <br />    It widely considered LS-BSF excrete pyruvate             analyses enzymatic assays (insets Fig. 6C). Second, RNAi- <br /> glucose metabolism, PF mainly produce acetate                       mediated down-regulation PDH-E2 performed Dtdh <br /> succinate. To compare glucose metabolism forms,                  background. Growth Dtdh/RNAiPDH.i cell lines was <br /> 2.56107 LS-BSF 56107 PF (equivalent 0.25 mg                         abolished days post-induction cell death seven days <br /> proteins) incubated 2.5 mL PBS containing 4 mM                     later (Fig. 6E). Addition 4 mM acetate medium does not <br /> glucose (Fig. 4) [U-13C]-glucose (Fig. 5A Table 1). 13C-               rescue growth Dtdh/RNAiPDH.i mutant (data shown) <br /> enriched end-products excreted medium [U-13C]-                    suggesting acetate and/or acetyl-coA need produced <br /> glucose metabolism quantified 1H-NMR (Table 1). It              inside mitochondrion feed essential mitochondrial <br /> note quantification errors significant, particular            fatty acid pathway, production the <br /> molecules representing 5% excreted end-products.             precursor butyryl-CoA [36]. This result confirms abolition of <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                       6                         December 2013 | Volume 7 | Issue 12 | e2587 <br />                                                                                                   Acetate Shuttle Is Essential BSF Trypanosomes <br />  <br />  <br />  <br />  <br /> Figure 3. AceCS essential growth lipid biosynthesis. Panel A shows growth curves parental 427 90-13 strain (WT) the <br /> RNAi <br />     AceCS mutant cell line incubated presence (.i) absence (.ni) 10 mg/mL tetracycline. Cells maintained exponential <br /> growth phase (between 26105 26106 cells/mL) cumulative cell numbers reflect normalization dilution cultivation. The cross <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                      7                        December 2013 | Volume 7 | Issue 12 | e2587 <br />                                                                                                        Acetate Shuttle Is Essential BSF Trypanosomes <br />  <br />  <br />  <br /> indicates cells dead. It noted addition 10 mg/mL tetracycline did affect growth parental cell line (see Fig. 6A). <br /> Panel B shows [1-14C]-acetate incorporation lipids WT tetracycline-induced (one days) uninduced RNAiAceCS cells. 14C-labeled <br /> fatty acid methyl esters separated HPTLC transesterification analyzed described Experimental Procedures section. The <br /> values normalized amounts total esters measured sample. Error bars indicate mean 6 SD 3 independent experiments. <br /> doi:10.1371/journal.pntd.0002587.g003 <br />  <br />  <br /> mitochondrial acetyl-CoA/acetate production glucose                   unenriched threonine order perform quantitative analysis <br /> and threonine lethal BSF grown standard medium.                       threonine-derived glucose-derived acetate production by <br />                                                                                 1 <br />                                                                                   H-NMR. When [U-13C]-glucose carbon source in <br /> Relative contribution glucose threonine acetate                       incubation medium, excreted [13C]-acetate (annotated A13 <br /> production                                                                      Fig. 5) represented doublets chemical shifts at <br />    To address question developed metabolite profiling                 2.0 ppm 1.75 ppm, respectively (see Fig. 5A). It to <br /> assay based ability 1H-NMR spectrometry distinguish                noted threonine metabolism analyzed indepen- <br /> 13 <br />    C-enriched molecules 12C ones. Cells incubated                  dently glucose essential BSF. Addition threonine to <br /> PBS equal amounts (4 mM) [U-13C]-glucose                            [U-13C]-glucose/PBS medium induced production threo- <br />                                                                                 nine-derived [12C]-acetate (386 nmol/h/108 cells) addition to <br />                                                                                 [13C]-glucose-derived [13C]-acetate (532 nmol/h/108 cells) <br />                                                                                 (Fig. 5B Table 2). This shows presence equal <br />                                                                                 amounts carbon sources, glucose contributes ,1.4-fold <br />                                                                                 threonine acetate production. <br />                                                                                    1 <br />                                                                                      H-NMR metabolite profiling single double mutants <br />                                                                                 confirmed involvement glucose threonine in <br />                                                                                 acetate production. As expected, production [13C]-glucose- <br />                                                                                 derived [13C]-acetate ,50-times lower RNAiPDH.i than <br />                                                                                 RNAiPDH.ni cells (16 versus 847 nmol/h/108 cells), while <br />                                                                                 threonine-derived acetate production affected. Converse- <br />                                                                                 ly, production threonine-derived acetate abolished the <br />                                                                                 Dtdh mutant, [13C]-glucose-derived [13C]-acetate not <br />                                                                                 affected (Table 2 Fig. 5C&#226;&#8364;&#8220;D). Finally, production acetate <br />                                                                                 carbon sources affected Dtdh/RNAiPDH.i <br />                                                                                 double mutant cell line (Table 2 Fig. 5E). <br />  <br />                                                                                 Threonine contributes acetate production BSF vivo <br />                                                                                     BALB/c mice immunocompromised Endoxan treatment <br />                                                                                 injected wild-type RNAiPDH cells kept or <br />                                                                                 doxycycline, stable tetracycline analog, drinking <br />                                                                                 water down-regulate expression PDH-E2. Animal <span id='am-10' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-11' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-13' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-14' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-16' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-18' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-19' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-20' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-22' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-23' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-25' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-28' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-30' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-31' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-32' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-35' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-37' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-38' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-39' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-41' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-43' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-44' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-45' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-50' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-52' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-53' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-54' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-58' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-59' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-60' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-62' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-67' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-68' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-69' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-71' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-73' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-75' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-77' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-81' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-82' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-83' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-84' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-85' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-86' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span>survival</span> <br />                                                                                 blood parasite levels monitored. No differences were <br />                                                                                 observed groups animals, parasite <br />                                                                                 density started rise day post-infection. All mice were <br />                                                                                 dead days 6&#226;&#8364;&#8220;7 post-infection (data shown). This shows that <br />                                                                                 acetate production glucose necessary viability of <br />                                                                                 T. brucei vivo, suggesting possible acetate source (threonine) <br />                                                                                 present blood absent threonine-depleted in <br />                                                                                 vitro culture medium. As mentioned above, mammalian blood <br />                                                                                 contains approximately 150 mM threonine [35,37], 10- <br />                                                                                 times higher threonine-depleted IMDM medium. The <br />                                                                                 RNAi <br />                                                                                      PDH.i cell line died IMDM medium containing 15, 37.5 <br />                                                                                 75 mM threonine, addition 150 mM amino acid <br />                                                                                 restored growth vitro (Fig. 6D), suggesting the <br />                                                                                 homeostatic threonine blood concentration (150 mM) sufficient <br />                                                                                 provide BSF required acetyl-CoA/acetate molecules. <br />                                                                                 Altogether, demonstrates BSF trypanosomes have <br />                                                                                 developed complementary self-sufficient ways maintain <br /> Figure 4. 1H-NMR analysis excreted end-products                         essential production acetate blood mammalian <br /> glucose LS-BSF PF. Metabolic end-products (pyruvate, Pyr;                hosts. <br /> acetate, Ace; alanine, Ala succinate, Suc) excreted wild-type <br /> 427 monomorphic BSF (A) PF cells (B) 4 mM glucose (Glc) <br /> were determined 1H-NMR. The experiment performed 2.5 mL               Discussion <br /> of PBS 2.56107 LS-BSF cells (A) 56107 PF cells (B). Each <br /> spectrum corresponds representative experiment set of <br />                                                                                    LS-BSF trypanosomes known glucose- <br /> at 3. A spectrum ranging 1.1 ppm 4 ppm            dependency satisfy ATP requirements [38]. Indeed, net <br /> shown.                                                                          production cellular ATP fulfilled glycolytic <br /> doi:10.1371/journal.pntd.0002587.g004                                           step catalyzed pyruvate kinase, produces pyruvate, the <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                         8                          December 2013 | Volume 7 | Issue 12 | e2587 <br />                                                                                                     Acetate Shuttle Is Essential BSF Trypanosomes <br />  <br />  <br />  <br />  <br /> Figure 5. 1H-NMR analysis excreted end-products glucose threonine metabolism. Metabolic end-products (pyruvate and <br /> acetate) excreted wild-type BSF cell line (A&#226;&#8364;&#8220;B), tetracycline-induced RNAiPDH.i mutant (C), Dtdh mutant (D) tetracycline-induced <br /> Dtdh/RNAiPDH.i mutant (E) D-[U-13C]-glucose and/or threonine determined 1H-NMR. The cells incubated PBS containing 4 mM D- <br /> [U-13C]-glucose (_GT) (_G) 4 mM threonine. Each spectrum corresponds representative experiment set 3. A <br /> part spectrum ranging 1.6 ppm 2.6 ppm shown. The resonances assigned indicated spectra: A12, acetate; A13, <br /> 13 <br />    C-enriched acetate; P12, pyruvate; P13, 13C-enriched pyruvate. <br /> doi:10.1371/journal.pntd.0002587.g005 <br />  <br />  <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                       9                         December 2013 | Volume 7 | Issue 12 | e2587 <br />                                                                                                               Acetate Shuttle Is Essential BSF Trypanosomes <br />  <br />  <br />  <br />  Table 1. Excreted end-products glucose T. brucei long-slender bloodstream form (BSF) procyclic form (PF) cell lines. <br />  <br />  <br />  Cell linea,   b <br />                                nc   Excreted molecules [13C-U]glucosed <br />  <br />                                     Acetate                 Succinate                  Pyruvate                 Alanine                 TOTAL <br />  <br />                                     nmol/h/108 cells (% excreted molecules) <br />  <br />  EATRO1125.T7T (PF)            5    789   6 170 (81.5)      156    6 43 (16.2)         23     6 44 (2.3)        NDe                     968     6 180 (100) <br />  427 90-13 (BSF)               9    446   6 159 (4.9)       71     6 62 (0.8)          7761   6 1878 (85.1)     837    6   230 (9.2)    9115    6 1828 (100) <br />  RNAi <br />     PDH.ni                     7    755   6 320 (7.3)       114    6 155 (1.1)         8631   6 1398 (83.1)     890    6   264 (8.5)    10390 6 1426 (100) <br />  RNAi <br />     PDH.i                      6    55    6 88 (0.7)        115    6 104 (1.4)         7288   6 2193 (89.1)     721    6   145 (8.8)    8179    6 2243 (100) <br />  Dtdh                          3    510   6 100 (6.5)       33     6 11 (0.4)          6625   6 652 (84.3)      695    6   190 (8.8)    7863    6 913 (100) <br />  Dtdh/RNAiPDH.ni               3    300   6 34 (3.5)        12     6 12 (0.1)          7445   6 223 (86.5)      852    6   113 (9.9)    8610    6 239 (100) <br />  Dtdh/RNAiPDH.i                3    33    6 58 (0.5)        2      6 4 (0.02)          6350   6 460 (90.3)      649    6   48 (9.2)     7034    6 365 (100) <br />  <br />                                                                         13                             1 <br />  The extracellular PBS medium trypanosomes incubated 4 mM [U- C]-glucose analyzed H-NMR spectrometry detect quantify excreted end- <br />  products. <br />  a <br />    .i: RNAi cell lines tetracycline-induced 5 10 days depending cell line experiments; .ni: uninduced RNAi cell lines. <br />  b <br />    PF BSF incubated 26107 cells/mL (0.1 mg proteins/mL) 107 cells/mL (0.1 mg proteins/mL), respectively. <br />  c <br />   Number experiments. <br />  d <br />    Mean 6 SD 3 9 experiments cells incubated PBS containing 4 mM [U-13C]-glucose 4 mM threonine (nmol/h/108 cells), percent of <br />  excreted molecules (values brackets) presented. <br />  e <br />    Not detectable. <br />  doi:10.1371/journal.pntd.0002587.t001 <br />  <br />  <br /> excreted glycolytic end-product. Excretion significant amounts                     clearly demonstrates LS-BSF maintained capacity to <br /> of partially oxidized end-products glycolysis,                       produce excrete acetate succinate glycolysis. The <br /> glycerol, succinate alanine, previously reported                         relatively high rate acetate succinate production (only ,2- <br /> [14,17,39,40]. However, late seventies emerged general                       fold higher PF), enzymes involved correspond- <br /> dogma pyruvate considered exclusive glycolytic                        ing metabolic pathways 5- 20-times abundant PF, <br /> end-product excreted LS-BSF aerobic conditions                             considerably higher glycolytic flux BSF. We <br /> [15,16], minor end-products assigned                       determined excretion rate glycolytic end-products is <br /> non-growing conditions contamination non-dividing SS-                         9.5-fold higher BSF PF (9115 versus 968 nmol of <br /> BSF [18,19]. Here, used experimental model 427                           excreted end-products/h/108 cells), consistent the <br /> BSF strain, lost ability differentiate SS-BSF,                  previously measured 5- 10-fold difference glycolytic flux [14]. <br /> in order focus analysis glucose metabolism LS-BSF                        A recent analysis glycolytic flux BSF strain <br /> trypanosomes. This laboratory-adapted monomorphic strain                           incubated growing conditions (IMDM containing 20 mM <br /> insensitive stumpy inductor factor, but, successfully                       glucose) showed higher rate pyruvate production compared <br /> differentiates vitro bona fide SS-BSF, instance                      analysis performed PBS containing 4 mM glucose and <br /> expression protein kinase target rapamycin (TOR4)                        threonine (19.2 versus 12.0 mmol/h/108 cells) [44]. The reduced <br /> inhibited [41]. This suggests 427 strain considered                   glycolytic flux observed PBS conditions certainly reflects the <br /> as slender-like BSF lost ability respond                     difference non-growing conditions (PBS) exponential <br /> stumpy inductor factor, relevant model study                    growth (IMDM) doubling time range 5 h [44]. <br /> the metabolism proliferative BSF. Our metabolic analyses                           Also, 35% reduction total end-product fluxes wild <br /> showed LS-BSF produce succinate                           type cells depending available substrates (PBS/glucose versus <br /> acetate glucose PF incubated conditions. This                     PBS/glucose/threonine) shows metabolic fluxes depen- <br /> suggests most, all, enzymes involved &#226;&#8364;&#732;&#226;&#8364;&#732;succinate                   dent exact context substrates present (Table 1). <br /> and acetate branches&#226;&#8364;&#8482;&#226;&#8364;&#8482; previously characterized PF                           It important note experimental procedures not <br /> expressed LS-BSF. To produce acetate, PDH (step 1 Fig. 1)                       reflect physiological conditions, trypanosomes incubat- <br /> converts pyruvate acetyl-CoA, substrate ASCT                     ed high density PBS containing 4 mM glucose. Consequent- <br /> (step 2) ACH (step 3) acetate production. ASCT expression                     ly, minor glycolytic end-products excreted a <br /> is low BSF (Fig. 2 [19]), ACH relatively abundant                     lower rate, all, LS-BSF trypanosomes vivo. A recent <br /> (Fig. 2) ACH activity ,2-fold higher PF (data                        quantitative analysis fate glucose exponentially growing <br /> shown). Three PDH subunits investigated                      427 LS-BSF vitro (the strain analysis here) showed that <br /> far expressed BSF (PDH-E1a PDH-E2, Fig. 2;                         pyruvate excreted glycolytic end-product [44]. Glucose, <br /> PDH-E3, [42]), PDH enzymatic activity 4-fold lower                        pyruvate glycerol analysed study. Although they <br /> than PF (Fig. 2). This relatively high PDH activity                          report complete carbon balance glucose uptake <br /> agreement recent comparative SILAC proteomics analysis                         pyruvate excretion, analysis leaves room small fluxes <br /> showing PDH-E1a, PDH-E1&#195;&#376;, PDH-E2 PDH-E3                                  products did analyse acetate and <br /> 5.3-, 7.6-, 5.2- 8.1-fold abundant PF LS-BSF,                        succinate. We report end-products, fluxes to <br /> respectively [43]. The proteomics analysis LS-BSF                        acetate succinate representing ,5% excreted <br /> detected most, all, enzymes involved succinate                       glycolytic end products. The exact fraction total carbon going to <br /> production phosphoenolpyruvate, lower level                        end-products difficult assign, errors in <br /> of expression PF (between 3- 20-fold). Altogether,                   quantification fluxes results did enable the <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                              10                           December 2013 | Volume 7 | Issue 12 | e2587 <br />                                                                                                    Acetate Shuttle Is Essential BSF Trypanosomes <br />  <br />  <br />  <br />  <br /> Figure 6. Analysis mutant cell lines. Panels A C&#226;&#8364;&#8220;E growth curve parental 427 90-13 BSF cells (WT) mutant cell lines <br /> incubated IMDM medium. The mutant cell lines RNAiPDH (A D), Dtdh (C) Dtdh/RNAiPDH (E) incubated presence (.i, +tet) in <br /> the absence (.ni) tetracycline. In panel D, RNAiPDH.i cell line incubated threonine-depleted medium supplemented 0 150 mM <br /> threonine. The cells maintained exponential growth phase (between 26105 26106 cells/mL) cumulative cell numbers reflect <br /> normalization dilution cultivation. The insets panels A C&#226;&#8364;&#8220;E western blot analyses parental (WT) mutant cell lines <br /> with immune sera indicated right margin. The lower inset panel C shows TDH activity (milliunits/mg protein) measured WT <br /> and Dtdh cell lines (ND stands detectable). Panel B shows PCR analysis genomic DNA isolated parental WT Dtdh cell lines. <br /> Amplifications performed primers based sequences flank 59UTR 39UTR fragments used target TDH gene depletion <br /> (black boxes) internal sequences puromycin (PAC, PCR products 3 5) blasticidin (BSD, PCR products 4 6) resistance genes. As <br /> controls, used primers corresponding 59UTR (PCR product 1), TDH, PAC BLE genes (PCR products 2, 7 8, respectively). As <br /> expected, PCR amplification 59UTR observed cell lines (lane 1), TDH gene PCR-amplified WT cells (lane 2) <br /> and PCR products marker-derived primers observed Dtdh cell line (lanes 3&#226;&#8364;&#8220;8). <br /> doi:10.1371/journal.pntd.0002587.g006 <br />  <br />  <br />  <br /> calculation carbon balance carbon uptake                     addition sodium acetate medium, cannot <br /> excretion. Whatever rate acetate excretion glucose                substitutes glucose-derived acetate production. <br /> metabolism exponentially growing LS-BSF is, production                 The above-mentioned reverse genetic experiments combined <br /> essential growth, exemplified death RNAiPDH.i            1H-NMR metabolic analyses clearly demonstrate that <br /> cell line incubated absence threonine, acetate            glucose threonine significant carbon sources <br /> source. This confirmed inducing cell death blocking               contributing essential production acetate 427 BSF <br /> acetate production carbon sources                            strain. To knowledge, report showing acetate <br /> Dtdh/RNAiPDH.i double mutant, growth correspond-                 production glucose LS-BSF, threonine been <br /> ing single mutants standard IMDM medium affected                   described acetate-source BSF [12,45]. Inhibition of <br /> (Fig. 6). The relevance acetate production glycolysis             single acetate-production pathway RNAiPDH.i Dtdh cell <br /> LS-BSF strengthened (i) high rate growth            lines grown standard IMDM medium does affect growth of <br /> of wild-type parasite, absence threonine (Fig. 6),         LS-BSF, indicating single active pathway sufficient for <br /> as recently observed development new minimal                      growth vitro. This probably true vivo, (i) glucose <br /> medium supports growth BSF [37] (ii) impossibility            concentration higher blood experimental <br /> to rescue growth Dtdh/RNAiPDH.i double mutant                       conditions (5 versus 4 mM) (ii) relatively low homeostatic <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                      11                        December 2013 | Volume 7 | Issue 12 | e2587 <br />                                                                                                         Acetate Shuttle Is Essential BSF Trypanosomes <br />  <br />  <br />  <br />  Table 2. Excreted end-products glucose threonine metabolism T. brucei long-slender bloodstream form (BSF) and <br />  procyclic form (PF) cell lines. <br />  <br />  <br />                               Excreted                                                                                                        Ratio <br />                               acetate                                                                                                    acetate <br />  Cell line   a, b <br />                       n   c <br />                               threonined     Excreted molecules [13C-U]Glucosed,e                                                        (Glu)/(Thr)f <br />                                              Acetate            Succinate          Pyruvate            Alanine             TOTAL <br />                                          8 <br />                               nmol/h/10 cells (% excreted molecules) <br />  <br />  EATRO1125.T7T (PF)   5       13066 210      668 6 127 (55.2)   308 6 92 (25.5)    207   6 98 (17.1)   27    6 60 (1.1)    1210 6 145 (100) 0.51 <br />  427 90-13 (BSF)      9       386 6 59       532 6 111 (3.8)    76   6 68 (0.6)    11964 6 2161 (86.0) 1342 6 266 (9.6)    14070 6 2437 (100) 1.38 <br />  RNAi <br />     PDH.ni            6       423 6 125      847 6 412 (6.5)    102 6 64 (0.8)     10918 6 3177 (83.4) 1223 6 536 (9.3)    13090 6 3496 (100) 2.00 <br />  RNAi <br />     PDH.i             5       373 6 211      16   6 62 (0.1)    189 6 166 (1.6)    10723 6 3344 (88.5) 1191 6 530 (9.8)    12119 6 4185 (100) 0.04 <br />  Dtdh                 3       NDg            899 6 169 (7.5)    39   6 19 (0.3)    9879 6 186 (81.7)   1272 6 451 (10.5) 12090 6 525 (100) .100 <br />  Dtdh/RNAiPDH.ni      3       ND             488 6 72 (4.3)     12   6 5 (0.1)     9595 6 348 (84.5)   1266 6 82 (11.1)    11361 6 479 (100) .100 <br />  Dtdh/RNAiPDH.i       3       ND             109 6 61 (1.2)     ND                 8098 6 744 (88.3)   965   6 206 (10.5) 9172 6 946 (100) .100 <br />  <br />  The extracellular PBS medium trypanosomes incubated 4 mM [U-13C]-glucose 4 mM threonine analyzed 1H-NMR spectrometry detect and <br />  quantify excreted end-products. <br />  a <br />    .i: RNAi cell lines tetracycline-induced 5 10 days depending cell line experiments; .ni: uninduced RNAi cell lines. <br />  b <br />    PF BSF incubated 26107 cells/mL (0.1 mg proteins/mL) 107 cells/mL (0.1 mg proteins/mL), respectively. <br />  c <br />    Number experiments. <br />  d <br />    Mean 6 SD 3 9 experiments cells incubated PBS containing 4 mM [U-13C]-glucose 4 mM threonine (nmol/h/108 cells) presented. <br />  e <br />    Values brackets represent percent excreted molecules [U-13C]-glucose metabolism. <br />  f <br />    Ratio glucose-derived threonine-derived [13C]-acetate excreted. <br />  g <br />    Not detectable. <br />  doi:10.1371/journal.pntd.0002587.t002 <br />  <br />  <br />  <br /> concentration threonine mammalian blood (150 mM)                         production required feed mitochondrial fatty acid biosynthesis, <br /> sufficient acetate production, demonstrated absence                 contribute ,10% cellular fatty acid production [36]. <br /> of growth effect RNAiPDH.i mutant medium containing                     As mentioned above, detection &#226;&#8364;&#732;&#226;&#8364;&#732;minor&#226;&#8364;&#8482;&#226;&#8364;&#8482; glycolytic <br /> least 150 mM threonine (Fig. 6D). When incubated equal                       end-products excreted BSF trypanosomes consistent with <br /> amounts threonine glucose (4 mM), parasite produces                    most, all, early reports [14,17,39,40] recent <br /> ,1.4-fold acetate glycolysis. Mammalian blood                           quantitative flux analysis BSF 427 [44]. The high glycolytic flux <br /> contains ,30-fold glucose threonine (5 mM versus                        combined exclusive conversion glucose into <br /> 150 mM), strengthens view contribution                      pyruvate probably caused community overlook these <br /> glucose acetate production relevant vivo. This contrasts            minor end-products metabolic pathways leading their <br /> an equivalent recent analysis performed procyclic form                  production, biosynthesis essential the <br /> T. brucei, prefers threonine acetate fatty acid                     parasite, described acetate. For instance, also <br /> productions, ,2.5-fold higher contribution threonine                    observed LS-BSF excretes alanine glucose (twice more <br /> compared glucose incubated 4 mM carbon                       acetate, Table 1), reported [17]. Alanine is <br /> sources [46].                                                                     produced pyruvate transfer amino group coming <br />    In PF trypanosomes, mitochondrial production acetate                 various possible amino acid sources. A recent metabolomic <br /> essential feed novo fatty acid biosynthesis &#226;&#8364;&#732;&#226;&#8364;&#732;acetate           analysis showed glutamate hydrophobic keto acids <br /> shuttle&#226;&#8364;&#8482;&#226;&#8364;&#8482; [13]. In shuttle, acetate produced mitochon-                accumulate BSF spent media, suggesting glutamine <br /> drion reaches cytosol, converted AceCS               hydrophobic amino acids possible substrates alanine <br /> into acetyl-CoA produce malonyl-CoA, elongator fatty                   aminotransferase alanine production [37]. The relevance of <br /> acid biosynthesis. It noteworthy microsomal                      alanine production glycolysis strengthened reported <br /> elongase-dependent mitochondrial type II fatty acid synthase                  accumulation hydrophobic keto acids plasma urine of <br /> pathways use malonyl-CoA elongate fatty acids [47]. As                         infected rodents [51,52] requirement alanine amino- <br /> observed PF, AceCS essential incorporation [1-14C]-                  transferase activity vitro growth parasite [53]. Succinate <br /> acetate LS-BSF fatty acids (Fig. 3), indicating AceCS                production glycolysis importance for <br /> required novo fatty acid synthesis. In addition, Gilbert et al.            biosynthetic pathways LS-BSF, exemplified require- <br /> previously showed glucose threonine used                     ment fumarate novo synthesis pyrimidine the <br /> carbon sources fatty acid synthesis [47]. Altogether,                    unusual fumarate-dependent dihydroorotate dehydrogenase [54]. <br /> demonstrates that, like PF, proliferative BSF trypanosomes use                Altogether, highlights need reconsider further <br /> &#226;&#8364;&#732;&#226;&#8364;&#732;acetate shuttle&#226;&#8364;&#8482;&#226;&#8364;&#8482; feed fatty acid biosynthetic pathways. The                 investigate metabolic pathways leading minor glycolytic <br /> essential role mitochondrial fatty acid synthesis                     end-products, considered negligible compared to <br /> documented BSF, however, RNAi-mediated regulation                      total carbon flux glucose [44], order reveal new <br /> elongase genes involved microsomal fatty acid biosynthesis                 essential metabolic pathways targeted develop <br /> does affect growth parasite [36,48,49,50]. Consequently,               new trypanocidal molecules. Beyond glycolysis, overlooked <br /> the lethal phenotype observed LS-BSF RNAiAceCS mutant                  metabolic pathways central metabolism need revisited <br /> probably dramatic reduction cytosolic malonyl-CoA                   LS-BSF, exemplified recent observation RNAi <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                          12                         December 2013 | Volume 7 | Issue 12 | e2587 <br />                                                                                                                          Acetate Shuttle Is Essential BSF Trypanosomes <br />  <br />  <br /> down-regulation tricarboxylic acid enzyme succinyl-CoA                                  Author Contributions <br /> synthetase induces spectacular death phenotypes <br />                                                                                                Conceived designed experiments: MM FB PMoreau. Performed <br /> observed BSF, 100% cell death 20 h post-                              experiments: MM PMorand MB GB PC YM. Analyzed data: MM <br /> induction [55], pathway considered repressed BSF.                             FB PMoreau PV SD JMF. Contributed reagents/materials/analysis tools: <br />                                                                                                MM PMorand MB GB PC YM. Wrote paper: MM FB. <br /> Acknowledgments <br /> We grateful Patricia Nabos (Universite&#194;&#180; Bordeaux Segalen) her <br /> invaluable technical support. <br />  <br /> References <br />  1. Barrett MP, Burchmore RJ, Stich A, Lazzari JO, Frasch AC, et al. (2003) The                27. Sambrook J, Fritsch EF, Maniatis T. (eds). (1989) Molecular cloning : a <br />     trypanosomiases. Lancet 362: 1469&#226;&#8364;&#8220;1480.                                                        laboratory manual., Chapters 18.47&#226;&#8364;&#8220;18.74, Cold Spring Harbor Laboratory Press, <br />  2. Fenn K, Matthews KR (2007) The cell biology Trypanosoma brucei                              New York <br />     differentiation. Curr Opin Microbiol 10: 539&#226;&#8364;&#8220;546.                                          28. Ebikeme C, Hubert J, Biran M, Gouspillou G, Morand P, et al. (2010) Ablation <br />  3. Bringaud F, Riviere L, Coustou V (2006) Energy metabolism trypanosoma-                      succinate production glucose metabolism procyclic trypanosomes <br />     tids: adaptation available carbon sources. Mol Biochem Parasitol 149: 1&#226;&#8364;&#8220;9.                  induces metabolic switches glycerol 3-phosphate/dihydroxyacetone <br />  4. Tielens AG, van Hellemond JJ (2009) Surprising variety energy metabolism                    phosphate shuttle proline metabolism. J Biol Chem 285: 32312&#226;&#8364;&#8220;32324. <br />     Trypanosomatidae. Trends Parasitol 25: 482&#226;&#8364;&#8220;490.                                     29. Bringaud F, Peyruchaud S, Baltz D, Giroud C, Simpson L, et al. (1995) <br />  5. Coustou V, Biran M, Breton M, Guegan F, Riviere L, et al. (2008) Glucose-                      Molecular characterization mitochondrial heat shock protein 60 gene <br />     induced remodelling intermediary energy metabolism procyclic                         Trypanosoma brucei. Mol Biochem Parasitol 74: 119&#226;&#8364;&#8220;123. <br />     Trypanosoma brucei. J Biol Chem 283: 16342&#226;&#8364;&#8220;16354.                                          30. Denise H, Giroud C, Barrett MP, Baltz T (1999) Affinity chromatography using <br />  6. Lamour N, Riviere L, Coustou V, Coombs GH, Barrett MP, et al. (2005) Proline                   trypanocidal arsenical drugs identifies specific interaction glycerol-3- <br />     metabolism procyclic Trypanosoma brucei down-regulated presence                phosphate dehydrogenase Trypanosoma brucei Cymelarsan. <br />     glucose. J Biol Chem 280: 11902&#226;&#8364;&#8220;11910.                                                         Eur J Biochem 259: 339&#226;&#8364;&#8220;346. <br />  7. Opperdoes FR, Borst P (1977) Localization glycolytic enzymes                  31. Klein RA, Linstead DJ, Wheeler MV (1975) Carbon dioxide fixation in <br />     microbody-like organelle Trypanosoma brucei: glycosome. FEBS Lett 80:                   trypanosomatids. Parasitology 71: 93&#226;&#8364;&#8220;107. <br />     360&#226;&#8364;&#8220;364.                                                                                   32. Else AJ, Clarke JF, Willis A, Jackman SA, Hough DW, et al. (1994) <br />  8. Van Hellemond JJ, Opperdoes FR, Tielens AG (1998) Trypanosomatidae produce                     Dihydrolipoamide dehydrogenase Trypanosoma subgenus, trypanozoon. <br />     acetate mitochondrial acetate:succinate CoA transferase. Proc Natl Acad                  Mol Biochem Parasitol 64: 233&#226;&#8364;&#8220;239. <br />     Sci USA 95: 3036&#226;&#8364;&#8220;3041.                                                                     33. Akoka S, Barantin L, Trierweiler M (1999) Concentration Measurement by <br />  9. Riviere L, van Weelden SW, Glass P, Vegh P, Coustou V, et al. (2004)                           Proton NMR Using ERETIC Method. Anal Chem 71: 2554&#226;&#8364;&#8220;2557. <br />     Acetyl:succinate CoA-transferase procyclic Trypanosoma brucei. Gene identifi-           34. Tollinger CD, Vreman HJ, Weiner MW (1979) Measurement acetate in <br />     cation role carbohydrate metabolism. J Biol Chem 279: 45337&#226;&#8364;&#8220;45346.                      human blood gas chromatography: effects sample preparation, feeding, <br /> 10. Millerioux Y, Morand P, Biran M, Mazet M, Moreau P, et al. (2012) ATP                          various diseases. Clin Chem 25: 1787&#226;&#8364;&#8220;1790. <br />     synthesis-coupled -uncoupled acetate production acetyl-CoA                 35. Ohnishi A, Osaki T, Matahira Y, Tsuka T, Imagawa T, et al. (2013) Correlation <br />     mitochondrial acetate:succinate CoA-transferase acetyl-CoA thioesterase                 plasma amino Acid concentrations chondroprotective effects of <br />     Trypanosoma. J Biol Chem 287: 17186&#226;&#8364;&#8220;17197.                                                     glucosamine fish collagen Peptide development osteoarthritis. <br /> 11. Cross GA, Klein RA, Linstead DJ (1975) Utilization amino acids                           J Vet Med Sci 75: 497&#226;&#8364;&#8220;502. <br />     Trypanosoma brucei culture: L-threonine precursor acetate. Parasitology        36. Stephens JL, Lee SH, Paul KS, Englund PT (2007) Mitochondrial fatty acid <br />     71: 311&#226;&#8364;&#8220;326.                                                                                   synthesis Trypanosoma brucei. J Biol Chem 282: 4427&#226;&#8364;&#8220;4436. <br /> 12. Linstead DJ, Klein RA, Cross GA (1977) Threonine catabolism Trypanosoma                 37. Creek DJ, Nijagal B, Kim DH, Rojas F, Matthews KR, et al. (2013) <br />     brucei. J Gen Microbiol 101: 243&#226;&#8364;&#8220;251.                                                          Metabolomics guides rational development simplified cell culture medium <br /> 13. Riviere L, Moreau P, Allmann S, Hahn M, Biran M, et al. (2009) Acetate                         drug screening Trypanosoma brucei. Antimicrob Agents Chemother <br />     produced mitochondrion essential precursor lipid biosynthesis              57(6):2768&#226;&#8364;&#8220;79. <br />     procyclic trypanosomes. Proc Natl Aca Sci USA 106: 12694&#226;&#8364;&#8220;12699.                            38. Fairlamb AH, Opperdoes FR (1986) Carbohydrate metabolism african <br /> 14. Ryley JF (1962) Studies metabolism protozoa. 9. Comparative                          trypanosomes, special reference glycosome. Carbohydrate <br />     metabolism bloodstream culture forms Trypanosoma rhodesiense.                        Metabolism Cultured Cells (Morgan, M. J. ed.), Plenum Publishing <br />     Biochem J 85: 211&#226;&#8364;&#8220;223.                                                                         Corporation. pp 183&#226;&#8364;&#8220;224. <br /> 15. Clarkson AB Jr, Brohn FH (1976) Trypanosomiasis: approach                            39. Fulton JD, Stevens TS (1945) The glucose metabolism vitro Trypanosoma <br />     chemotherapy inhibition carbohydrate catabolism. Science 194:                        rhodesiense. Biochem J 39: 317&#226;&#8364;&#8220;320. <br />     204&#226;&#8364;&#8220;206.                                                                                   40. Ryley JF (1956) Studies metabolism Protozoa. 7. Comparative <br /> 16. Visser N, Opperdoes FR (1980) Glycolysis Trypanosoma brucei. Eur J Biochem                  carbohydrate metabolism species trypanosome. Biochem J 62: 215&#226;&#8364;&#8220; <br />     103: 623&#226;&#8364;&#8220;632.                                                                                  222. <br /> 17. Grant PT, Fulton JD (1957) The catabolism glucose strains Trypanosoma             41. Barquilla A, Saldivia M, Diaz R, Bart JM, Vidal I, et al. (2012) Third target of <br />     rhodesiense. Biochem J 66: 242&#226;&#8364;&#8220;250.                                                            rapamycin complex negatively regulates development quiescence in <br /> 18. Creek DJ, Anderson J, McConville MJ, Barrett MP (2012) Metabolomic analysis                    Trypanosoma brucei. Proc Natl Aca Sci USA 109: 14399&#226;&#8364;&#8220;14404. <br />     trypanosomatid protozoa. Mol Biochem Parasitol 181: 73&#226;&#8364;&#8220;84.                              42. Roldan A, Comini MA, Crispo M, Krauth-Siegel RL (2011) Lipoamide <br /> 19. van Grinsven KW, Van Den Abbeele J, Van den Bossche P, van Hellemond JJ                        dehydrogenase essential bloodstream procyclic Trypanosoma brucei. <br />     Tielens AG (2009). Adaptations glucose metabolism procyclic                      Mol Microbiol 81: 623&#226;&#8364;&#8220;639. <br />     Trypanosoma brucei isolates tsetse flies differentiation                43. Gunasekera K, Wuthrich D, Braga-Lagache S, Heller M, Ochsenreiter T (2012) <br />     bloodstream forms. Eukaryot Cell 8: 1307&#226;&#8364;&#8220;1311.                                                 Proteome remodelling development blood insect-form Trypano- <br /> 20. Cross GA, Manning JC (1973) Cultivation Trypanosoma brucei sspp. semi-                   soma brucei quantified SILAC mass spectrometry. BMC Genomics 13: <br />     defined defined media. Parasitology 67: 315&#226;&#8364;&#8220;331.                                           556. <br /> 21. Peacock L, Ferris V, Bailey M, Gibson W (2008) Fly transmission mating              44. Haanstra JR, van Tuijl A, van Dam J, van Winden W, Tielens AG, et al. (2012) <br />     Trypanosoma brucei brucei strain 427. Mol Biochem Parasitol 160: 100&#226;&#8364;&#8220;106.                      Proliferating bloodstream-form Trypanosoma brucei use negligible of <br /> 22. Hirumi H, Hirumi K (1989) Continuous cultivation Trypanosoma brucei blood                   consumed glucose anabolic processes. Int J Parasitol 42: 667&#226;&#8364;&#8220;673. <br />     stream forms medium containing low concentration serum protein                   45. Gilbert RJ, Klein RA, Miller PG (1983) The role threonine metabolism <br />     feeder cell layers. J Parasitol 75: 985&#226;&#8364;&#8220;989.                                           acetyl coenzyme Trypanosoma brucei brucei. Comp Biochem Physiol B 74: <br /> 23. Brun R, Schonenberger M (1979) Cultivation vitro cloning procyclic                   277&#226;&#8364;&#8220;281. <br />     culture forms Trypanosoma brucei semi-defined medium. Acta Trop 36:                46. Millerioux Y, Ebikeme C, Biran M, Morand P, Bouyssou G, et al. (2013). The <br />     289&#226;&#8364;&#8220;292.                                                                                       threonine degradation pathway Trypanosoma brucei procyclic form: main <br /> 24. Wirtz E, Leal S, Ochatt C, Cross GA (1999) A tightly regulated inducible                       carbon source lipid biosynthesis metabolic control. Mol Microbiol <br />     expression conditional gene knock-outs dominant-negative                        90(1):114&#226;&#8364;&#8220;29. <br />     genetics Trypanosoma brucei. Mol Biochem Parasitol 99: 89&#226;&#8364;&#8220;101.                          47. Vigueira P.A., Paul K.S. (2011) Requirement acetyl-CoA carboxylase in <br /> 25. Burkard G, Fragoso CM, Roditi I (2007) Highly efficient stable transformation                  Trypanosoma brucei dependent growth environment. Mol Microbiol 80: <br />     bloodstream forms Trypanosoma brucei. Mol Biochem Parasitol 153: 220&#226;&#8364;&#8220;223.                117&#226;&#8364;&#8220;132. <br /> 26. Harlow E, Lane D (1988) In Antibodies: laboratory manual, pp. 471&#226;&#8364;&#8220;502,                   48. Lee SH, Stephens JL, Paul KS, Englund PT (2006) Fatty acid synthesis by <br />     Cold Spring Harbor Laboratory Press.                                                           elongases trypanosomes. Cell 126: 691&#226;&#8364;&#8220;699. <br />  <br />  <br />  <br /> PLOS Neglected Tropical Diseases | www.plosntds.org                                       13                             December 2013 | Volume 7 | Issue 12 | e2587 <br />                                                                                                                      Acetate Shuttle Is Essential BSF Trypanosomes <br />  <br />  <br /> 49. Lee SH, Stephens JL, Englund PT (2007) A fatty-acid synthesis mechanism                 53. Spitznagel D, Ebikeme C, Biran M, Nic a&#226;&#8364;&#8482; Bhaird N, Bringaud F, et al. (2009) <br />     specialized parasitism. Nat Rev Microbiol 5: 287&#226;&#8364;&#8220;297.                                   Alanine aminotransferase Trypanosoma brucei - key role proline metabolism <br /> 50. Smith TK, Butikofer P (2010) Lipid metabolism Trypanosoma brucei. Mol                    procyclic life forms. FEBS J 276: 7187&#226;&#8364;&#8220;7199. <br />     Biochem  <br /> </body></html>